Literature DB >> 3991396

Hyperprolactinaemia in male diabetics.

A D Mooradian, J E Morley, C J Billington, M F Slag, M K Elson, R B Shafer.   

Abstract

We recently investigated two patients with diabetes and elevated serum prolactin levels in whom no cause of hyperprolactinaemia could be found. For this reason we measured fasting serum prolactin levels in 72 diabetic males and compared the results with those of 63 healthy males and 90 nondiabetic males attending an Impotence Clinic. The diabetic group had significantly higher serum prolactin levels (13.1 +/- 0.9 ng/ml) than the two control groups (9.9 +/- 0.6 ng/ml for normal males and 7.7 +/- 0.3 ng/ml for the non-diabetic impotent group). Eighteen percent of the diabetics studied had serum prolactin levels above the normal range for males (greater than 20 ng/ml). There was no correlation between serum prolactin levels and duration of diabetes, glycosylated haemoglobin level or presence of clinically apparent retinopathy. The correlation between serum prolactin level and fasting plasma glucose was weak though statistically significant (r = 0.26, P less than 0.05).

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3991396      PMCID: PMC2418110          DOI: 10.1136/pgmj.61.711.11

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


  19 in total

1.  Letter: Diabetic retinopathy and prolactin.

Authors:  P R Hunter; J Anderson; T A Lunn; D F Horrobin; A R Boyns; E N Cole
Journal:  Lancet       Date:  1974-06-15       Impact factor: 79.321

2.  A homologous radioimmunoassay for human prolactin.

Authors:  Y N Sinha; F W Selby; U J Lewis; W P VanderLaan
Journal:  J Clin Endocrinol Metab       Date:  1973-03       Impact factor: 5.958

Review 3.  Necrosis of anterior pituitary in humans. II.

Authors:  K Kovács
Journal:  Neuroendocrinology       Date:  1969       Impact factor: 4.914

4.  Diabetic retinopathy and prolactin.

Authors:  M Harter; N Balarac; P Pourcher; J M Koslowski; B Krebs; A Ramaioli
Journal:  Lancet       Date:  1976-10-30       Impact factor: 79.321

5.  Diet and prolactin release.

Authors:  P Hill; F Wynder
Journal:  Lancet       Date:  1976-10-09       Impact factor: 79.321

6.  Lack of effect of hyperprolactinemia on glucose disposal and insulin secretion in patients with prolactinomas.

Authors:  E J Katz; R A Donald; D W Beaven; E A Espiner
Journal:  Horm Metab Res       Date:  1981-12       Impact factor: 2.936

7.  Pituitary responsiveness to thyrotropin releasing hormone in insulin-dependent diabetes mellitus.

Authors:  J E Morley; C Klein; W J Kalk; B I Joffe; D Saffer; L A Distiller; H C Seftel
Journal:  Horm Metab Res       Date:  1978-05       Impact factor: 2.936

8.  Increased serum prolactin in diabetic ketoacidosis; correlation between serum sodium and serum prolacting concentration.

Authors:  K F Hanssen; P A Torjesen
Journal:  Acta Endocrinol (Copenh)       Date:  1977-06

9.  Hyperprolactinaemia and impotence.

Authors:  S Franks; H S Jacobs; N Martin; J D Nabarro
Journal:  Clin Endocrinol (Oxf)       Date:  1978-04       Impact factor: 3.478

10.  Prolactin: a diabetogenic hormone.

Authors:  R Landgraf; M M Landraf-Leurs; A Weissmann; R Hörl; K von Werder; P C Scriba
Journal:  Diabetologia       Date:  1977-04       Impact factor: 10.122

View more
  8 in total

Review 1.  The Interplay Between Pituitary Health and Diabetes Mellitus - The Need for 'Hypophyseo-Vigilance'.

Authors:  Saptarshi Bhattacharya; Sanjay Kalra; Deep Dutta; Deepak Khandelwal; Rajiv Singla
Journal:  Eur Endocrinol       Date:  2019-10-18

Review 2.  The endocrine system in diabetes mellitus.

Authors:  Hisham Alrefai; Hisham Allababidi; Shiri Levy; Joseph Levy
Journal:  Endocrine       Date:  2002-07       Impact factor: 3.633

3.  The GABAergic control of prolactin release is not affected by insulin-dependent diabetes mellitus: evidence from studies with sodium valproate.

Authors:  V Coiro; C Davoli; R Volpi; E Sorini; E Voltini; G Rossi; R Delsignore; A Gnudi; P Chiodera
Journal:  Acta Diabetol Lat       Date:  1986 Jan-Mar

4.  High levels of serum prolactin protect against diabetic retinopathy by increasing ocular vasoinhibins.

Authors:  Edith Arnold; José C Rivera; Stéphanie Thebault; Daniel Moreno-Páramo; Hugo Quiroz-Mercado; Andrés Quintanar-Stéphano; Nadine Binart; Gonzalo Martínez de la Escalera; Carmen Clapp
Journal:  Diabetes       Date:  2010-09-07       Impact factor: 9.461

Review 5.  Impotence in elderly men.

Authors:  J E Morley; F E Kaiser
Journal:  Drugs Aging       Date:  1992 Jul-Aug       Impact factor: 3.923

6.  Promotion of epithelial-mesenchymal transformation by hepatocellular carcinoma-educated macrophages through Wnt2b/β-catenin/c-Myc signaling and reprogramming glycolysis.

Authors:  Yu Jiang; Qiuju Han; Huajun Zhao; Jian Zhang
Journal:  J Exp Clin Cancer Res       Date:  2021-01-06

Review 7.  Prolactin and vasoinhibin are endogenous players in diabetic retinopathy revisited.

Authors:  Jakob Triebel; Thomas Bertsch; Carmen Clapp
Journal:  Front Endocrinol (Lausanne)       Date:  2022-09-09       Impact factor: 6.055

Review 8.  Interactions Between the Neuroendocrine System and T Lymphocytes in Diabetes.

Authors:  Luz Andreone; María Laura Gimeno; Marcelo J Perone
Journal:  Front Endocrinol (Lausanne)       Date:  2018-05-17       Impact factor: 5.555

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.